Free Trial
NASDAQ:SAVA

Cassava Sciences (SAVA) Stock Price, News & Analysis

Cassava Sciences logo
$2.16 -0.03 (-1.37%)
Closing price 07/10/2025 04:00 PM Eastern
Extended Trading
$2.13 -0.03 (-1.16%)
As of 08:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cassava Sciences Stock (NASDAQ:SAVA)

Key Stats

Today's Range
$2.13
$2.21
50-Day Range
$1.51
$2.24
52-Week Range
$1.15
$42.20
Volume
626,398 shs
Average Volume
2.88 million shs
Market Capitalization
$104.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$54.50
Consensus Rating
Moderate Buy

Company Overview

Cassava Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

SAVA MarketRank™: 

Cassava Sciences scored higher than 76% of companies evaluated by MarketBeat, and ranked 241st out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cassava Sciences has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Cassava Sciences has received no research coverage in the past 90 days.

  • Read more about Cassava Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Cassava Sciences are expected to grow in the coming year, from ($3.97) to ($0.62) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cassava Sciences is -1.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cassava Sciences is -1.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cassava Sciences has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Cassava Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    17.43% of the float of Cassava Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Cassava Sciences has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in Cassava Sciences has recently decreased by 6.91%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cassava Sciences does not currently pay a dividend.

  • Dividend Growth

    Cassava Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    17.43% of the float of Cassava Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Cassava Sciences has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in Cassava Sciences has recently decreased by 6.91%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Cassava Sciences this week, compared to 7 articles on an average week.
  • Search Interest

    Only 12 people have searched for SAVA on MarketBeat in the last 30 days. This is a decrease of -45% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Cassava Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cassava Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.40% of the stock of Cassava Sciences is held by insiders.

  • Percentage Held by Institutions

    Only 38.05% of the stock of Cassava Sciences is held by institutions.

  • Read more about Cassava Sciences' insider trading history.
Receive SAVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cassava Sciences and its competitors with MarketBeat's FREE daily newsletter.

SAVA Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Cassava Sciences Inc.
See More Headlines

SAVA Stock Analysis - Frequently Asked Questions

Cassava Sciences' stock was trading at $2.36 at the beginning of the year. Since then, SAVA stock has decreased by 8.5% and is now trading at $2.16.

Cassava Sciences, Inc. (NASDAQ:SAVA) announced its quarterly earnings results on Thursday, May, 8th. The company reported ($0.48) earnings per share for the quarter.

Cassava Sciences's stock split before market open on Thursday, December 21st 2023.The 14-10 split was announced on Thursday, December 21st 2023. The newly issued shares were distributed to shareholders after the closing bell on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the split would have 140 shares after the split.

Shares of SAVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cassava Sciences investors own include Waste Connections (WCN), Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/08/2025
Today
7/11/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SAVA
CIK
1069530
Employees
30
Year Founded
N/A

Price Target and Rating

High Price Target
$107.00
Low Price Target
$2.00
Potential Upside/Downside
+2,423.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.50)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$24.34 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-87.72%
Return on Assets
-72.05%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.08
Quick Ratio
9.08

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.03 per share
Price / Book
0.71

Miscellaneous

Outstanding Shares
48,310,000
Free Float
47,149,000
Market Cap
$104.35 million
Optionable
Optionable
Beta
-2.04
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:SAVA) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners